Drug Discovery · Houston, TX · Founded 2017 · Privately Held (backing)
Operator of a biotechnology company focused on developing a natural killer cell therapy with potent activity to treat cancer. Indapta Therapeutics is based in Houston, TX and was founded in 2017. Its last reported valuation was $90 million in May 2023. It has raised $162 million across 4 recorded rounds; the latest was a $50.8 million later-stage round in Sep 2025.
Last reported valuation
$90.0M
Oct 2026
Priced at
—
Total raised
$162.3M
Last round
Later Stage VC
Sep 2025
Team — not yet on record
No current team members for Indapta Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Indapta Therapeutics with a free account
·The complete investor list: 11 names
·Watch Indapta Therapeutics: the Monday email on marks, rounds and moves
